Identification of new bradyzoite surface antigens for use in toxoplasma gondii vaccines and diagnostics

Informations projet

ANNA BRILLOWSKA-DABR

N° de convention de subvention: QLK2-CT-2001-50970

Date de début 1 Janvier 2002

Date de fin 31 Decembre 2003

Financé au titre de

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Coût total € 144 352,00

Contribution de l’UE € 144 352,00

Coordonné par

STATENS SERUM INSTITUT
Denmark

Objectif

In order to select new potentially vaccine genes from T. goodie, Expressed Sequence Tags (EST) database will be search and the gene fragment meets the criteria, further will be full length sequenced and then characterized

Champ scientifique

• natural sciences › computer and information sciences › databases
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thème(s)

• 1.1.1.-2. - Key action Control of Infectious Diseases

Appel à propositions

Data not available

Régime de financement

RGI - Research grants (individual fellowships)

Coordinateur

STATENS SERUM INSTITUT

• Contribution de l’UE: Aucune donnée
• Adresse: 5,Artillerivej 5 ; 2300 KOEPENHAGEN ; Danemark
• Coût total: Aucune donnée